Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
BMJ Open|February 12, 2022
Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson's disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD)Taku Hatano, Genko Oyama, Yasushi Shimo, et al.
Nature Medicine|May 29, 2023
Propagative α-synuclein seeds as serum biomarkers for synucleinopathiesAyami Okuzumi, Taku Hatano, Gen Matsumoto, et al.
American Journal of Human Genetics|July 8, 2005
An autosomal dominant cerebellar ataxia linked to chromosome 16q22.1 is associated with a single-nucleotide substitution in the 5' untranslated region of the gene encoding a protein with spectrin repeat and Rho guanine-nucleotide exchange-factor domainsKinya Ishikawa, Shuta Toru, Taiji Tsunemi, et al.
Human Molecular Genetics|February 9, 2013
Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficitsPatrick J Schultheis, Sheila M Fleming, Amy K Clippinger, et al.
Journal of Alzheimer'S Disease Reports|January 1, 2026
Baseline characteristics of patients with early Alzheimer's disease enrolled in the pivotal trial of low-intensity pulsed ultrasound (LIPUS-AD)Hiroaki Shimokawa, Masahiro Akishita, Takashi Asada, et al.
Nature Medicine|December 8, 2015
PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeuticallyAudrey S Dickey, Victor V Pineda, Taiji Tsunemi, et al.
Movement Disorders Clinical Practice|January 24, 2024
Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST-PD StudyTaku Hatano, Genko Oyama, Yasushi Shimo, et al.
Brain : a Journal of Neurology|March 24, 2020
Variants in saposin D domain of prosaposin gene linked to Parkinson's diseaseYutaka Oji, Taku Hatano, Shin-Ichi Ueno, et al.
JAMA Neurology|May 9, 2022
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical TrialRyosuke Oki, Yuishin Izumi, Koji Fujita, et al.
Pageof 6